Axon's Dedrone C2 upgrades, strategic partnerships and rising CUAS demand are fueling momentum after revenues topped $100 million in Q2 2026.
A sell-the-news reaction to a strong quarter can create the perfect setup for a powerful rebound. Jeremy Mullin explains how to recognize these irrational moves and outlines three steps to trade them for big returns.
Axon's strong Q2 revenue growth and raised outlook support its long-term prospects, but high costs, debt and valuation temper near-term appeal.
Axon delivered robust Q2 results, with 35% YoY revenue growth and strong AI Era business momentum. Future demand remains solid, evidenced by a 41% YoY increase in bookings and improved net revenue retention to 126%. Gross margin contracted 40 bps YoY, but adjusted EBITDA margin expanded 110 bps, highlighting operational leverage.
Axon tops revenue estimates as strong demand across connected devices and software prompt higher 2026 revenue growth guidance despite an EPS miss.
Axon lifts 2026 revenue growth outlook to 32%-34% after Q2 earnings as software, AI and Dedrone demand expands, even as memory cost pressure near-term margins.
Axon Enterprise, Inc. (AXON) Q2 2026 Earnings Call Transcript
The headline numbers for Axon (AXON) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
TASER-maker Axon Enterprise posted lower second-quarter gross margin on Wednesday, weighed by a higher mix of less lucrative professional services and investments in scaling new product offerings.
Axon Enterprise (AXON) came out with quarterly earnings of $1.88 per share, missing the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $2.12 per share a year ago.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Beyond analysts' top-and-bottom-line estimates for Axon (AXON), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.